Watson, Sandoz settle Medicaid whistleblower suits for $145M

Watson Pharmaceuticals ($WPI) and Novartis' ($NVS) generics unit Sandoz have agreed to settle False Claims Act lawsuits alleging  they overstated the prices on drugs sold to Medicaid programs. Watson agreed to pay $79 million, and Sandoz will cough up $66 million. Report

Suggested Articles

German viral vector CDMO Vibalogics has hired Lonza veteran Tom Hochuli as global CEO to help lead its U.S. expansion efforts.

Merck’s Keytruda already boasts an OK in some esophageal cancer patients, but it’s looking to widen its reach in the tough-to-treat disease.

GI cancers are stubborn, as plenty of oncology drugmakers know. But BMS' Opdivo has broken through with two potentially practice-changing trials.